Chinese researchers find neutralizing antibody against COVID-19 variants
BEIJING - Chinese researchers have found a neutralizing antibody that could provide protection against the Delta and Omicron variants of COVID-19, and it has shown preventative efficacy by nasal delivery.
The antibody 58G6 detected in a COVID-19 patient was isolated and showed potent neutralizing activity inhibiting the variants, according to the study published in the journal Signal Transduction and Targeted Therapy.
It was jointly discovered by researchers from the Chongqing Medical University and the Wuhan Institute of Virology under the Chinese Academy of Sciences.
The researchers administered the antibody to hamsters via nasal delivery and found that a very low dosage of 2 milligrams per kilogram effectively prevented them from being infected with the variants, according to the paper.
It said that the antibody is expected to be used in nebulized therapy.
- Mainland vows safety for Taiwan compatriots amid Middle East tensions, criticizes DPP’s political manipulation
- Zhengding Folk Art Performance draws 30 troupes for Lantern Festival
- China advances in quantum technology, sets global records with new innovations: national political adviser
- Adrian Cheng: HK needs to build platforms for international and local talent exchange
- Mainland offers to resume cross-Strait dialogue if DPP acknowledges 1992 Consensus
- China's top political advisory body starts annual session
